.jpg)
.png)
15th Anniversary
Lipid therapeutics over the past three decades have focused on oral drugs that targeted lipid metabolism through mechanisms that regulate clearance of apoprotein B-containing lipoproteins (through the LDL receptor, such as statins, bile acid resins and ezetimibe) or the synthesis/clearance of... more
I was asked to write a perspective on a look back of the past five years on the NLA and clinical lipidology. It is impossible to state all the advances made in clinical lipidology and the contributions our organization has made over the past five years in a short and focused perspective. Therefore... more
In the year 2001, we began a new millennium, but for many of us a more important beginning occurred the next year with the formation of the National Lipid Association. I had the good fortune to be there with my colleagues as we made the decision to convince Christopher Seymour to become our... more
I’m always reminded of how fortunate I have been to serve the National Lipid Association (NLA) in various capacities and to watch the organization grow and mature over time. I have seen tremendous growth in member engagement in various NLA activities, as well as a renewed sense of comradery... more
The Foundation of the NLA has already had an extremely eventful 2017 with many new, exciting plans for its future and direction. The Foundation Board of Directors met in January to discuss our goals, strategy and upcoming plans. The discussions at this meeting led to a new mission, vision and... more
As practicing clinicians, we all continue to face the challenge of remaining up to date with the rapid pace of advancing science in our field. As I consider different options to accomplish this goal in 2017, none can compare to active participation in the wide variety of educational activities... more
It is an exciting time to be the president of the National Lipid Association as we celebrate our 15th Anniversary. The successes and accomplishments of this and the past years are built on the strong leadership and counsel that we have enjoyed from the inception of the organization. An appropriate... more
How has your professional training and background shaped your career in lipids? After completing Cardiology training in Boston, I worked under the mentorship of Dr. David Blankenhorn at the University of Southern California for 14 years. His expertise and passion for the field was instilled in... more
Dr. Don P. Wilson, a Fellow of the National Lipid Association, began his career with the National Lipid Association (NLA) in 2006. Dr. Wilson received his medical degree from the University of Mississippi and completed his internship and pediatric residency training at Baylor College of Medicine in... more
Please give us a little introduction about yourself. I am currently working as a Dean of the School of Pharmacy and Health Profession at Creighton University. This is my 13th year in this position. Because I am more involved in administrative side of the academics and not too involved in the... more